Japan's regulator renews warning on off-label GLP-1 use for cosmetic weight loss
Japan's medicines regulator, the PMDA, has again called for proper use of GLP-1 and GIP/GLP-1 drugs after several reports of side effects linked to off-label use for cosmetic weight loss. It echoes UK regulators' push for proper eligibility checks before prescribing.
Image credit: Pharma Japan
Source: Pharma Japan (2 Nov 2026). Image: Pharma Japan.